ArticleBlood2013
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.
Joshua J Oaks et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
69 papers cite itlatest 60 shown
this paperpooled itcites it